These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25985954)

  • 21. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition.
    Biswas S; Carta F; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Apr; 21(8):2314-2318. PubMed ID: 23490152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
    Wang WL; Chen XY; Gao Y; Gao LX; Sheng L; Zhu J; Xu L; Ding ZZ; Zhang C; Li JY; Li J; Zhou YB
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5154-5157. PubMed ID: 29100798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors. Synthesis of topically effective intraocular pressure lowering agents derived from 5-(omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide.
    Barboiu M; Supuran CT; Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G
    J Enzyme Inhib; 2000; 15(1):23-46. PubMed ID: 10850953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents.
    Supuran CT; Casini A; Mastrolorenzo A; Scozzafava A
    Mini Rev Med Chem; 2004 Aug; 4(6):625-32. PubMed ID: 15279596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,3,4-thiadiazole: a privileged scaffold for drug design and development.
    Han X; Yu YL; Hu YS; Liu XH
    Curr Top Med Chem; 2021; 21(28):2546-2573. PubMed ID: 34766891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II.
    Mert S; Alım Z; İşgör MM; Beydemir Ş; Kasımoğulları R
    Bioorg Chem; 2016 Oct; 68():64-71. PubMed ID: 27454619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles.
    Kumar D; Vaddula BR; Chang KH; Shah K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2320-3. PubMed ID: 21429743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues.
    Mathew V; Keshavayya J; Vaidya VP; Giles D
    Eur J Med Chem; 2007 Jun; 42(6):823-40. PubMed ID: 17331622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amide derivatives with pyrazole carboxylic acids of 5-amino-1,3,4-thiadiazole 2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibitory effects.
    Bülbül M; Kasimoğullari R; Küfrevioğlu OI
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):895-900. PubMed ID: 18618324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs].
    Guo J; Li FR; Liu Y; Cheng MS
    Yao Xue Xue Bao; 2013 Nov; 48(11):1637-43. PubMed ID: 24475699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.
    Ibrahim DA
    Eur J Med Chem; 2009 Jul; 44(7):2776-81. PubMed ID: 19203813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors.
    Abbate F; Casini A; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):303-8. PubMed ID: 14567544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
    Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
    Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
    Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.